BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 27349799)

  • 21. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.
    Ott N; Faletti L; Heeg M; Andreani V; Grimbacher B
    J Clin Immunol; 2023 Aug; 43(6):1326-1359. PubMed ID: 37140667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
    Sansone P; Bromberg J
    J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.
    Ni Y; Low JT; Silke J; O'Reilly LA
    Front Immunol; 2022; 13():835997. PubMed ID: 35844493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance.
    Raychaudhuri SP; Shah RJ; Banerjee S; Raychaudhuri SK
    Curr Rheumatol Rep; 2024 Jun; 26(6):204-213. PubMed ID: 38492148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.
    Stabile H; Scarno G; Fionda C; Gismondi A; Santoni A; Gadina M; Sciumè G
    Immunol Rev; 2018 Nov; 286(1):148-159. PubMed ID: 30294965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic targeting of the Jak/STAT pathway.
    Aittomäki S; Pesu M
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):18-23. PubMed ID: 24164900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
    Alunno A; Padjen I; Fanouriakis A; Boumpas DT
    Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK/STAT signaling pathway and its regulation on insect immunity.
    Wei XY; Hu DC; Gao ZP; Feng CJ
    Yi Chuan; 2023 Mar; 45(3):229-236. PubMed ID: 36927649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
    Richter P; Cardoneanu A; Burlui AM; Macovei LA; Bratoiu I; Buliga-Finis ON; Rezus E
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
    Park H; Lee S; Lee J; Moon H; Ro SW
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The JAK/STAT signaling cascade in gastric carcinoma (Review).
    Khanna P; Chua PJ; Bay BH; Baeg GH
    Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
    Venugopal S; Bar-Natan M; Mascarenhas JO
    Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
    Liu J; Wang F; Luo F
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases.
    Shen P; Wang Y; Jia X; Xu P; Qin L; Feng X; Li Z; Qiu Z
    Eur J Med Chem; 2022 Sep; 239():114551. PubMed ID: 35749986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
    Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
    Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tools and methods for studying the Drosophila JAK/STAT pathway.
    Chen Q; Giedt M; Tang L; Harrison DA
    Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
    Favoino E; Prete M; Catacchio G; Ruscitti P; Navarini L; Giacomelli R; Perosa F
    Autoimmun Rev; 2021 Mar; 20(3):102750. PubMed ID: 33482338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.